# A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

> **NCT07511114** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 156 (estimated)

## Conditions studied

- DLBCL - Diffuse Large B Cell Lymphoma
- Double Expressor Lymphoma

## Interventions

- **DRUG:** C-Pola-R-CHP+X
- **DRUG:** CR-CHOP

## Key facts

- **NCT ID:** NCT07511114
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2028-03-31
- **Final completion:** 2030-03-31
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07511114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07511114, "A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07511114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*